Research and Development 2021

Views & Analysis
Card image cap

The landscape for UK R&D SMEs post-COVID

Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has enabled the UK to respond swiftly to the pandemic.

Views & Analysis
Card image cap

Digitalising drug discovery

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is ver